Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1992;1(3):197–199. doi: 10.1155/S0962935192000309

Serum levels of interleukin-6 are not dependent on the kidney function

L Nässberger 1
PMCID: PMC2365338  PMID: 18475461

Abstract

Interleukin-6, also named B-cell stimulatory factor, is a glycoprotein with a molecular weight of 26 kDa. Increased serum levels of interleukin-6 (IL-6) are found in several disease conditions. We investigated the importance of a deteriorated kidney function upon IL-6 serum concentrations. No relation was found between serum levels of IL-6 and s-creatinine, r = 0.004. On the other hand, the serum concentration of complement protein factor D and soluble IL-2 receptor showed a good correlation to s-creatinine, r = 0.92 and 0.79, respectively. In conclusion, serum levels of IL-6 are not dependent upon a reduced kidney function.

Full Text

The Full Text of this article is available as a PDF (284.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bendtzen K., Svenson M., Jønsson V., Hippe E. Autoantibodies to cytokines--friends or foes? Immunol Today. 1990 May;11(5):167–169. doi: 10.1016/0167-5699(90)90068-k. [DOI] [PubMed] [Google Scholar]
  2. Bocci V. Interleukins. Clinical pharmacokinetics and practical implications. Clin Pharmacokinet. 1991 Oct;21(4):274–284. doi: 10.2165/00003088-199121040-00004. [DOI] [PubMed] [Google Scholar]
  3. Gordon C., Richards N., Howie A. J., Richardson K., Michael J., Adu D., Emery P. Urinary IL-6: a marker for mesangial proliferative glomerulonephritis? Clin Exp Immunol. 1991 Oct;86(1):145–149. doi: 10.1111/j.1365-2249.1991.tb05787.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hack C. E., De Groot E. R., Felt-Bersma R. J., Nuijens J. H., Strack Van Schijndel R. J., Eerenberg-Belmer A. J., Thijs L. G., Aarden L. A. Increased plasma levels of interleukin-6 in sepsis. Blood. 1989 Oct;74(5):1704–1710. [PubMed] [Google Scholar]
  5. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 1986 Nov 6;324(6092):73–76. doi: 10.1038/324073a0. [DOI] [PubMed] [Google Scholar]
  6. James K. Interactions between cytokines and alpha 2-macroglobulin. Immunol Today. 1990 May;11(5):163–166. doi: 10.1016/0167-5699(90)90067-j. [DOI] [PubMed] [Google Scholar]
  7. Kampschmidt R. F., Jones T. Rate of clearance of interleukin-1 from the blood of normal and nephrectomized rats. Proc Soc Exp Biol Med. 1985 Oct;180(1):170–173. doi: 10.3181/00379727-180-42160. [DOI] [PubMed] [Google Scholar]
  8. Konrad M. W., Hemstreet G., Hersh E. M., Mansell P. W., Mertelsmann R., Kolitz J. E., Bradley E. C. Pharmacokinetics of recombinant interleukin 2 in humans. Cancer Res. 1990 Apr 1;50(7):2009–2017. [PubMed] [Google Scholar]
  9. Lantz M., Thysell H., Nilsson E., Olsson I. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. J Clin Invest. 1991 Dec;88(6):2026–2031. doi: 10.1172/JCI115530. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  10. LeMay L. G., Vander A. J., Kluger M. J. The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol Behav. 1990 May;47(5):957–961. doi: 10.1016/0031-9384(90)90024-x. [DOI] [PubMed] [Google Scholar]
  11. Martin A., Lachmann P. J., Halbwachs L., Hobart M. J. Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation. Immunochemistry. 1976 Apr;13(4):317–324. doi: 10.1016/0019-2791(76)90341-4. [DOI] [PubMed] [Google Scholar]
  12. Metsärinne K., Teppo A. M., Grönhagen-Riska C., Fyhrquist F. Increased plasma interleukin 6 and renin substrate levels during bacterial peritonitis in CAPD patients. Clin Nephrol. 1991 Aug;36(2):104–104. [PubMed] [Google Scholar]
  13. Miki S., Iwano M., Miki Y., Yamamoto M., Tang B., Yokokawa K., Sonoda T., Hirano T., Kishimoto T. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett. 1989 Jul 3;250(2):607–610. doi: 10.1016/0014-5793(89)80805-1. [DOI] [PubMed] [Google Scholar]
  14. Nijsten M. W., de Groot E. R., ten Duis H. J., Klasen H. J., Hack C. E., Aarden L. A. Serum levels of interleukin-6 and acute phase responses. Lancet. 1987 Oct 17;2(8564):921–921. doi: 10.1016/s0140-6736(87)91413-9. [DOI] [PubMed] [Google Scholar]
  15. Nishimoto N., Yoshizaki K., Tagoh H., Monden M., Kishimoto S., Hirano T., Kishimoto T. Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol. 1989 Mar;50(3):399–401. doi: 10.1016/0090-1229(89)90147-5. [DOI] [PubMed] [Google Scholar]
  16. Seckinger P., Zhang J. H., Hauptmann B., Dayer J. M. Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5188–5192. doi: 10.1073/pnas.87.13.5188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sturfelt G., Truedsson L., Thysell H., Björck L. Serum level of complement factor D in systemic lupus erythematosus--an indicator of glomerular filtration rate. Acta Med Scand. 1984;216(2):171–177. doi: 10.1111/j.0954-6820.1984.tb03789.x. [DOI] [PubMed] [Google Scholar]
  18. Tovey M. G., Gresser I., Blanchard B., Guymarho J. Expression of IL-6 in normal individuals and in patients with autoimmune disease. Ann N Y Acad Sci. 1989;557:363–373. doi: 10.1111/j.1749-6632.1989.tb24029.x. [DOI] [PubMed] [Google Scholar]
  19. Uyttenhove C., Coulie P. G., Van Snick J. T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor. J Exp Med. 1988 Apr 1;167(4):1417–1427. doi: 10.1084/jem.167.4.1417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Van Damme J., Opdenakker G., Simpson R. J., Rubira M. R., Cayphas S., Vink A., Billiau A., Van Snick J. Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med. 1987 Mar 1;165(3):914–919. doi: 10.1084/jem.165.3.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Van Oers M. H., Van der Heyden A. A., Aarden L. A. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol. 1988 Feb;71(2):314–319. [PMC free article] [PubMed] [Google Scholar]
  22. Wibell L., Evrin P. E., Berggård I. Serum 2 -microglobulin in renal disease. Nephron. 1973;10(5):320–331. doi: 10.1159/000180203. [DOI] [PubMed] [Google Scholar]
  23. Wong G. G., Clark S. C. Multiple actions of interleukin 6 within a cytokine network. Immunol Today. 1988 May;9(5):137–139. doi: 10.1016/0167-5699(88)91200-5. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES